Insider Insights
01.03.2022
Spotlight on access to orphan drugs

The Ministry of Health hhas published a report on the “evolution of funding and fixing of the pric...

Read more
Insider Insights
24.02.2022
Legislation-extends-CPR-and-CTS-membership

The National Recovery and Resilience Plan had extended the membership to the CPR and CTS until 28th...

Read more
Insider Insights
21.02.2022
Eligibility for prescribing testosterone

The change is intended to simplify care pathways and the management of patients requiring testoster...

Read more
Insider Insights
18.02.2022
Pharmacy chains reduce price of contraceptive pill

Superdrug has reduced the price of a generic version of the emergency hormonal contraceptive pill (l...

Read more
Insider Insights
14.02.2022
Fall in wholesale margins on prescription drugs

Wholesale margins on prescription drugs fell to 3.99% in 2021 (down from 4.09% in the previous year)...

Read more
Articles
02.02.2022
Developing a STA/HST submission to NICE

NICE require a broad range of evidence to be included within the reimbursement dossier, including cl...

Read more
Insider Insights
01.02.2022
Increasing prescribing controls on new medicines

According to data from the Ministry of Health 65.1% of medicines admitted to reimbursement in 2021 w...

Read more
Articles
01.02.2022
Changes to NICE's health technology evaluation

This reforms have been welcomed by the industry as they should support faster access to medicines as...

Read more
Insider Insights
01.02.2022
Voluntary payment percentage set at 15

All other aspects of the voluntary scheme remain unchanged.

Read more
Insider Insights
01.02.2022
NICE changes to its methods and processes

The changes cover how topics are chosen, the steps and stages in each evaluation and how evidence is...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.